To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Gadopentetate dimeglumine (Gd-DTPA) was the first paramagnetic magnetic resonance imaging (MRI) contrast enhancer. Introduced in 1981, it has been used to assist imaging of blood vessels and the surrounding tissue by injection into the desired tissue. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood-brain barrier. Gd-DTPA is a gadolinium complex of diethylenetriamine pentaacetic acid with ionic paramagnetic properties.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Gadopentetate_dimeglumine". A list of authors is available in Wikipedia.|